Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011, Article ID 308965, 10 pages
http://dx.doi.org/10.1155/2011/308965
Research Article

Immunomodulatory Effects of Aerobic Training in Obesity

1Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig-Maximilians-Universität München, Marchioninistr.15, 81377 Munich, Germany
2Department of Prevention and Sports Medicine, Technische Universität München, Klinikum rechts der Isar (MRI), 80809 Munich, Germany
3Sports Medicine, Institute of Exercise and Health Sciences, University Basel, 4003 Basel, Switzerland
4Institute for Medical Informatics Biometry and Epidemiology, Ludwig-Maximilians-Universität München, 81377 Munich, Germany

Received 3 August 2010; Revised 24 November 2010; Accepted 3 January 2011

Academic Editor: Natalija Novak

Copyright © 2011 Thomas Nickel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. T. Shamshiev, F. Ampenberger, B. Ernst, L. Rohrer, B. J. Marsland, and M. Kopf, “Dyslipidemia inhibits Toll-like receptor-induced activation of CD8α-negative dendritic cells and protective Th1 type immunity,” Journal of Experimental Medicine, vol. 204, no. 2, pp. 441–452, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. M. Clark, L. Hartling, B. Vandermeer, and F. A. McAlister, “Meta-analysis: secondary prevention programs for patients with coronary artery,” Annals of Internal Medicine, vol. 143, no. 9, pp. 659–I87, 2005. View at Google Scholar · View at Scopus
  3. N. Orsini, C. S. Mantzoros, and A. Wolk, “Association of physical activity with cancer incidence, mortality, and survival: a population-based study of men,” British Journal of Cancer, vol. 98, no. 11, pp. 1864–1869, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. N. Murthy, S. Mukherjee, G. Ray, and A. Ray, “Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies,” Journal of Postgraduate Medicine, vol. 55, no. 1, pp. 45–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. S. Yusuf, S. Hawken, S. Ôunpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9438, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. P. Bastard, M. Maachi, C. Lagathu et al., “Recent advances in the relationship between obesity, inflammation, and insulin resistance,” European Cytokine Network, vol. 17, no. 1, pp. 4–12, 2006. View at Google Scholar · View at Scopus
  7. C. Kasapis and P. D. Thompson, “The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1563–1569, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. T. Yamaji, M. Iwasaki, S. Sasazuki, and S. Tsugane, “Interaction between adiponectin and leptin influences the risk of colorectal adenoma,” Cancer Research, vol. 70, no. 13, pp. 5430–5437, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Matsubara, S. Maruoka, and S. Katayose, “Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women,” European Journal of Endocrinology, vol. 147, no. 2, pp. 173–180, 2002. View at Google Scholar · View at Scopus
  10. A. Martí, A. Marcos, and J. A. Martínez, “Obesity and immune function relationships,” Obesity Reviews, vol. 2, no. 2, pp. 131–140, 2001. View at Google Scholar · View at Scopus
  11. O. Lamas, A. Marti, and J. A. Martínez, “Obesity and immunocompetence,” European Journal of Clinical Nutrition, vol. 56, no. 3, pp. S42–S45, 2002. View at Google Scholar · View at Scopus
  12. S. R. Simonson, “The immune response to resistance exercise,” Journal of Strength and Conditioning Research, vol. 15, no. 3, pp. 378–384, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Gleeson, B. McFarlin, and M. Flynn, “Exercise and Toll-like receptors,” Exercise Immunology Review, vol. 12, pp. 34–53, 2006. View at Google Scholar · View at Scopus
  14. G. J. Randolph, V. Angeli, and M. A. Swartz, “Dendritic-cell trafficking to lymph nodes through lymphatic vessels,” Nature Reviews Immunology, vol. 5, no. 8, pp. 617–628, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. T. Nickel, D. Schmauss, H. Hanssen et al., “oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation,” Atherosclerosis, vol. 205, no. 2, pp. 442–450, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. L. Kapsenberg, “Dendritic-cell control of pathogen-driven T-cell polarization,” Nature Reviews Immunology, vol. 3, no. 12, pp. 984–993, 2003. View at Google Scholar · View at Scopus
  17. C. Meisel, J. M. Schwab, K. Prass, A. Meisel, and U. Dirnagl, “Central nervous system injury-induced immune deficiency syndrome,” Nature Reviews Neuroscience, vol. 6, no. 10, pp. 775–786, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. Y. V. Bobryshev, R. S. A. Lord, S. Rainer, O. S. Jamal, and V. F. Munro, “Vascular dendritic cells and atherosclerosis,” Pathology Research and Practice, vol. 192, no. 5, pp. 462–467, 1996. View at Google Scholar · View at Scopus
  19. S. Carpenter and L. A. J. O'Neill, “How important are Toll-like receptors for antimicrobial responses?” Cellular Microbiology, vol. 9, no. 8, pp. 1891–1901, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Google Scholar · View at Scopus
  21. S. Kofler, T. Nickel, and M. Weis, “Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation,” Clinical Science, vol. 108, no. 3, pp. 205–213, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. J. S. Fletcher and J. L. Banasik, “Exercise self-efficacy,” Clinical Excellence for Nurse Practitioners, vol. 5, no. 3, pp. 134–143, 2001. View at Google Scholar · View at Scopus
  23. T. Nickel, H. Hanssen, Z. Sisic et al., “Immunoregulatory effects of the flavonol quercetin in vitro and in vivo,” European Journal of Nutrition. In press. View at Publisher · View at Google Scholar · View at PubMed
  24. J. Narbutt, A. Lesiak, M. Zakprelich et al., “The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the Polish population,” Cellular and Molecular Biology Letters, vol. 9, no. 3, pp. 497–509, 2004. View at Google Scholar · View at Scopus
  25. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. B. Hou, B. Reizis, and A. L. DeFranco, “Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms,” Immunity, vol. 29, no. 2, pp. 272–282, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. P. Švec, B. Vásárhelyi, B. Pászthy et al., “Do regulatory T cells contribute to Th1 skewness in obesity?” Experimental and Clinical Endocrinology and Diabetes, vol. 115, no. 7, pp. 439–443, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. R. Smith, “Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk,” Obesity, vol. 14, supplement 3, pp. 128S–134S, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. A. K. L. Robertson, X. Zhou, B. Strandvik, and G. K. Hansson, “Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen,” Scandinavian Journal of Immunology, vol. 59, no. 3, pp. 285–293, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. C. J. Binder, K. Hartvigsen, M. K. Chang et al., “IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis,” Journal of Clinical Investigation, vol. 114, no. 3, pp. 427–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. G. Netea, P. N. M. Demacker, N. de Bont et al., “Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice,” Infection and Immunity, vol. 65, no. 7, pp. 2663–2667, 1997. View at Google Scholar · View at Scopus
  32. S. E. Roselaar, P. X. Kakkanathu, and A. Daugherty, “Lymphocyte populations in atherosclerotic lesions of ApoE -/- and LDL receptor -/- mice: decreasing density with disease progression,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 8, pp. 1013–1018, 1996. View at Google Scholar · View at Scopus
  33. N. de Bont, M. G. Netea, P. N. M. Demacker et al., “Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection,” Journal of Lipid Research, vol. 40, no. 4, pp. 680–685, 1999. View at Google Scholar · View at Scopus
  34. B. Ludewig, M. Jäggi, T. Dumrese et al., “Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic t cell responses,” Journal of Immunology, vol. 166, no. 5, pp. 3369–3376, 2001. View at Google Scholar · View at Scopus
  35. T. Akazawa, M. Shingai, M. Sasai et al., “Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors,” FEBS Letters, vol. 581, no. 18, pp. 3334–3340, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. L. Bellik, G. Gerlini, A. Parenti et al., “Role of conventional treatments on circulating and monocyte-derived dendritic cells in colorectal cancer,” Clinical Immunology, vol. 121, no. 1, pp. 74–80, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. F. Wertel, G. Polak, J. Roliński, B. Barczyński, and J. Kotarski, “Myeloid and lymphoid dendritic cells in the peritoneal fluid of women with ovarian cancer,” Advances in Medical Sciences, vol. 51, pp. 174–177, 2006. View at Google Scholar · View at Scopus
  38. H. F. Liao, L. M. Chiang, C. C. Yen et al., “Effect of a periodized exercise training and active recovery program on antitumor activity and development of dendritic cells,” Journal of Sports Medicine and Physical Fitness, vol. 46, no. 2, pp. 307–314, 2006. View at Google Scholar · View at Scopus
  39. C. Malm, “Exercise immunology: the current state of man and mouse,” Sports Medicine, vol. 34, no. 9, pp. 555–566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. L. M. Chiang, Y. J. Chen, J. Chiang, L. Y. Lai, Y. Y. Chen, and H. F. Liao, “Modulation of dendritic cells by endurance training,” International Journal of Sports Medicine, vol. 28, no. 9, pp. 798–803, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. A. Yilmaz, T. Schaller, I. Cicha et al., “Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease,” Clinical Science, vol. 116, no. 4, pp. 353–363, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. J. L. Witztum, “Immunological response to oxidized LDL,” Atherosclerosis, vol. 131, supplement, pp. S9–S11, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. J. A. Berliner, M. Navab, A. M. Fogelman et al., “Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics,” Circulation, vol. 91, no. 9, pp. 2488–2496, 1995. View at Google Scholar · View at Scopus
  44. N. Craft, K. W. Bruhn, B. D. Nguyen et al., “The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine,” Journal of Immunology, vol. 175, no. 3, pp. 1983–1990, 2005. View at Google Scholar · View at Scopus
  45. M. G. Flynn, B. K. McFarlin, M. D. Phillips, L. K. Stewart, and K. L. Timmerman, “Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women,” Journal of Applied Physiology, vol. 95, no. 5, pp. 1833–1842, 2003. View at Google Scholar · View at Scopus
  46. L. K. Stewart, M. G. Flynn, W. W. Campbell et al., “Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4,” Brain, Behavior, and Immunity, vol. 19, no. 5, pp. 389–397, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. C. Pasare and R. Medzhitov, “Toll-like receptors: linking innate and adaptive immunity,” Microbes and Infection, vol. 6, no. 15, pp. 1382–1387, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. G. S. Hotamisligil, “The role of TNFα and TNF receptors in obesity and insulin resistance,” Journal of Internal Medicine, vol. 245, no. 6, pp. 621–625, 1999. View at Publisher · View at Google Scholar · View at Scopus